Veterinary Vaccines

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• A. Companion Animal Vaccines
• B. Livestock Vaccines
  • Porcine Vaccines
  • Bovine Vaccines
  • Poultry Vaccines
  • Ovine Vaccines
  • Equine Vaccines
  • Other Animal Vaccines

II. EXECUTIVE SUMMARY

1. Industry Overview & Outlook

• Global Animal Health Care Industry - A Brief Review
• Table 1: Global Animal Health Products Market by Region (2007): Percentage Share Breakdown by Value Sales for Europe, North America, Latin America and Rest of World (includes corresponding Graph/Chart)
• Table 2: Global Animal Health Products Market by Product Group (2007): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart)
• Scope of the Report
• Current And Future Analysis

2. Market Trends & Issues

• Companion Animal Vaccines: Trailing on a High Growth Track
• OTC Market: A Potential Threat for Veterinarians
• Parasiticides, Systemic Agents To Drive The Market
• Taxonomy of Vaccines
• Bird Flu - The Aftermath
• Vaccination - Critical for Controlling Avian Influenza Virus

3. Product Overview

• Vaccines - An Evolutionary Scan
• Contribution of Animal Research to Vaccine Production
• Veterinary Medicines- A Brief Review
• Preventive Medicines
• Therapeutic Medicines
• Others
• Veterinary Vaccines - An Essential Component of Animal Health Care
• What Does A Veterinary Vaccine Do?
• Classification of Veterinary Vaccines
• Companion Animal Vaccines
• Canine Vaccines
• Feline Vaccines
• Livestock Vaccines
• Bovine Vaccines
• Poultry Vaccines
• Ovine Vaccines
• Porcine Vaccines
• Equine Vaccines
• Aquaculture Vaccines
• A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
• Vaccination and Its Reactions
• Veterinary Vaccines- Latest Breakthroughs
• Marker vaccines
• DNA vaccines
• Gene-deleted vaccines
• Viral-vectored vaccines

4. Notes on Select Animal Diseases

• Brucellosis
• Tuberculosis
• Johne' s disease
• Spirochete Associated Diseases
• Respiratory Disease in Goats, Sheep, and Cattle
• Porcine Respiratory Diseases
• Mastitis
• African Swine Fever
• Avian Influenza
• East Coast Fever
• Hemorrhagic Septicemia
• Foot-And-Mouth Disease
• Japanese Encephalitis
• Rift Valley Fever

5. Product Innovations/Introductions

• Intervet Develops Bluetongue Vaccine
• Agroinsuvet Introduces New Vaccines
• Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry
• Intervet & FLI Develop Dual Vaccine Prototype for Birds
• Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine
• USDA Approves Use of PreveNile™ Vaccine for Horses
• Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine
• Boehringer Ingelheim' s Swine Vaccine Gains Approval in Australia
• Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs
• Embrex' s Poultry Vaccine Inovocox Gets USDA Approval
• Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine
• USDA Grants Conditional License for Necrotic Enteritis Vaccine
• Fort Dodge Receives USDA License for Pyramid®10
• USDA Licenses Use of Fort Dodge' s Suvaxyn® PCV2 Vaccine in Pigs
• USDA Grants Conditional License to Pfizer' s New Canine Vaccine
• Continuum ™ DAP Vaccine from Intervet
• Lohmann Unveils Vaccine for Gumboro Disease
• New Vaccine for Bovine Respiratory Disease
• Corpoica & Limor Introduce Cattle Vaccine
• Chiron to Roll Out Rabies Vaccine in China
• Heska Launches Feline UltraNasal™ Vaccines
• Merial Unveils Two PUREVAX® Respiratory Vaccines

6. Recent Industry Activity

• Bayer Inks Agreement with Juvaris
• Pfizer Inks Agreement with IVT
• Vivalis Extends Research Collaboration with Kaketsuken
• Merial Bags Major Australian Contract
• USDA Approves Intervet Vaccine
• Merial Pockets Ancare
• Heska Revises Distribution Agreement with AgriLabs
• Animal Health International Acquires Kane Veterinary
• Industrial Equity Investments Pockets Arysta LifeScience
• Henry Schein Acquires W&J Dunlop
• Tecnovax Establishes New Facility
• Pingtung Agricultural to Set Up an Exclusive Veterinary Park
• Ouro Fino To Expand Veterinary Product Suite
• Alpharma Acquires Yantai Jinhai
• Pfizer Animal Health Acquires Embrex
• Schering-Plough Acquires Intervet
• Schering-Plough Acquires Organon
• Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer
• Crucell Licenses PER.C6® Technology to Pfizer Animal Health
• CVRL to Synthesize New Animal Vaccines
• Pfizer to Shut Down Omaha Animal Vaccine Center
• IGI Inc Licenses Novasomes to Novavax
• IPB Collaborates with Shigeta for Vaccine Production
• Suguna Poultry Steps into Livestock Vaccine Production Business
• European Medicines Agency Grants Community Authorization for Nobilis Influenza H7N1
• AVANT & Pfizer Collaborate to Develop Animal Vaccines
• Intervet Acquires FMD Vaccine Production Facility from Bayer Healthcare
• CFIA Authorizes Bioniche E. Coli O157: H7 Cattle Vaccine for Field Use
• Hemispherx Biopharma Acquires DOGS Molecule Patent
• Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala
• Cryosite and Animal Health Australia Form Partnership
• Hester Pharmaceuticals Plans Capacity Expansion
• Biovet Pvt Ltd to Set up Animal Vaccine Plant in Karnataka
• IPB and Shigeta Establish JV for Production of CLOSE 5.1 Vaccine
• IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune
• Bioject Signs Three Agreements With Merial
• PetCARE signs US distribution agreement with Butler Animal Health Supply
• Poultry Vaccine to be produced in Vladimir
• DEFRA Against Vaccine Usage For Bird Flu
• Butler & Burns Complete Business Merger
• Ivax Completes Phoenix Scientific' s Acquisition
• Crucell Signs Licensing Agreement with Merial
• Charlesbank Acquires Walco
• Imugene Signs an Agreement with Abic Biological
• Vical Licenses Core Technology to Merial
• Pfizer Acquires CSL' s Veterinary Vaccines Business
• Antigenics Sells Feline Leukemia Vaccine Unit
• Embrex Establishes Novel In Ovo Vaccine Plant
• Indian Immunological Bags Order for Foot and Mouth Disease Vaccine
• Crucell Issues West Nile Virus Vaccine License to Pfizer
• Kimron Veterinary Signs a License Agreement with Crucell
• Akzo Constructs Manufacturing Unit in Boxmeer

7. Research and Development

• Scientists Develop New Vaccine Against Disease Related to PCV2
• Auburn University and Vaxin Researchers Develop Avian Flu Vaccine
• UK Researchers Develop In-Shell Vaccine for Chicks
• Researchers in Vietnam Decode the H5N1 Virus Gene
• Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus
• University of Warwick Develops Protecting Virus Method
• New Treatment Measure Against Ovine Salmonella & Brucellosis
• ICAR Develops Indigenous Bird Flu Vaccine
• St. Jude Develops Flu Virus Vaccine through Reverse Genetics
• Researchers Develop Vaccine for Swine Disease
• Researchers Develop Experimental Vaccine Against 1918 Influenza Virus
• Study Proves Effectiveness of Intradermal Vaccine Administration in Rabbits
• CEL-SCI' s CEL-1000 Peptide Shows Adjuvant Activity
• Progress in Vaccine for Canine Cancer
• Vaccine for Avian Flu Developed
• Vector for DNA Vaccine Developed
• Bovine Herpesvirus 1 VP22Improves the Efficiency of DNA Vaccine
• Vaccine Against Canine Flu Underway
• Study on Immunity in Dogs
• New Sheep Vaccine in Clinical Trials
• Commercialization of Poultry Vaccine Underway
• Vaccine for B. Anthracis Developed
• Efficacy of E.Coli 0157 Vaccine Demonstrated
• Calgary-based Biotechnology Company to develop Oral Vaccine for Cattle Against Pneumonia
• Vaccine for Tick-Borne Disease Underway
• Feline Immunodeficiency Virus Rhinotracheitis Vaccine for Cats Under Trials
• Japanese Study on Bird Flu Vaccine

8. Focus on Select Global Players

• AVANT Immunotherapeutics, Inc (USA)
• Megan Health, Inc. (USA)
• Bayer HealthCare AG (Germany)
• Fort Dodge Animal Health (USA)
• Heska Corporation (USA)
• Imugene Limited (Australia)
• Merial Animal Health Ltd. (UK)
• Pfizer, Inc. (USA)
• Embrex, Inc. (USA)
• Protein Sciences Corporation (USA)
• Schering-Plough Corporation (USA)
• Intervet International B.V. (The Netherlands)
• Intervet, Inc. (USA)
• Virbac Corporation (USA)

9. Global Market Perspective

• Table 3: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 4: World Long-term Projections for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 5: World 10-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 6: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 7: World Long-term Projections for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)
• Table 8: World 10-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 9: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 10: World Long-term Projections for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 11: World 10-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2003, 2008 & 2012
• Table 12: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 13: World Long-term Projections for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 14: World 10 - Year Perspective for Canine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 15: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 16: World Long-term Projections for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 17: World 10 - Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 18: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 19: World Long-term Projections for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 20: World 10 - Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 21: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 22: World Long-term Projections for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 23: World 10-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 24: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 25: World Long-term Projections for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 26: World 10 - Year Perspective for Porcine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 27: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 28: World Long-term Projections for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 29: World 10 - Year Perspective for Bovine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 30: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 31: World Long-term Projections for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 32: World 10 - Year Perspective for Poultry Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 33: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 34: World Long-term Projections for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 35: World 10 - Year Perspective for Ovine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 36: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 37: World Long-term Projections for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 38: World 10 - Year Perspective for Equine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 39: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 40: World Long-term Projections for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 41: World 10 - Year Perspective for Other Animal Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current & Future Analysis
  • H5N1 Virus: A Conundrum for the US Industry
  • Rabies Cases in the US (2005)
  • Historic Data
  • Table 42: Leading Players in the US Rabies Vaccines Market (1995): Percentage Market Share for Pfizer, Fort Dodge, Solvay, Rhone Merieux and Others (includes corresponding Graph/Chart)
  • Strategic Developments
  • Product Launches/ Developments
  • Key US Players
  • AVANT Immunotherapeutics, Inc (USA)
  • Megan Health Inc.
  • Fort Dodge Animal Health
  • Heska Corporation
  • Intervet, Inc.
  • Pfizer Inc
  • Embrex, Inc
  • Protein Sciences Corporation
  • Schering-Plough Corporation
  • Virbac Corporation
• B. Market Analytics
  • Table 43: US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 44: US Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 45: US 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2. Europe

• A. Market Analysis
  • Current & Future Analysis
  • By Segment
  • Strategic Development
• B. Market Analytics
  • Table 46: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 47: European Long-term Projections for Veterinary Vaccines by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 48: European 10-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, United Kingdom and Rest of Europe for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 49: European Recent Past, Current & Future Analysis of Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 50: European Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 51: European 10 - Year Perspective for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2a. France

• A. Market Analysis
  • Current & Future Analysis
  • Strategic Development
• B. Market Analytics
  • Table 52: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 53: French Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 54: French 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2b. Germany

• A. Market Analysis
  • Current & Future Analysis
  • Strategic Developments
  • Key German Players
  • Bayer HealthCare AG
• B. Market Analytics
  • Table 55: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 56: German Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 57: German 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2c. Italy

• Market Analysis
• Table 58: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 59: Italian Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 60: Italian 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2d. The United Kingdom

• A. Market Analysis
  • Current & Future Analysis
  • Strategic Corporate Developments
  • Product Launches
  • Key Player in UK
  • Merial Animal Health Ltd
• B. Market Analytics
  • Table 61: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 62: UK Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 63: UK 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2e. Rest of Europe

• A. Market Analysis
  • Overview
  • A Note on Danish Veterinary Services
  • The 2002 Standards of Danish Medicines recommend test for antibody inducing fragments in veterinary vaccines
  • Hungary Vaccinates Birds Across Zoos
  • Russia Mass-Produces Vaccines Against Avian Flu
  • Product Launches/Developments
  • Strategic Developments
  • Focus on Select Players
  • Intervet International B.V. (The Netherlands)
• B. Market Analytics
  • Table 64: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 65: Rest of Europe Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 66: Rest of Europe 10-Year Perspective for Veterinary Vaccines by Product/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Rest of World

• A. Market Analysis
  • Overview
  • Focus on Select Regions
  • Canada
  • Overview of Canadian Animal Health Industry
  • Import and Manufacture of Veterinary Biologics
  • First to Access E. coli 0157: H7 Vaccine
  • China
  • An Emerging Veterinary Vaccine Hub
  • China Initiates Mass Vaccination Campaign Against Bird Flu Virus
  • Australia
  • A Note on Australian Veterinary Therapeutics Market
  • India
  • ICAR Develops Indigenous Bird Flu Vaccine
  • Thailand
  • Japan & Thailand to Cooperate for Developing Bird Flu Vaccine
  • Malaysia
  • Malaysia Initiates Measures to Deal with Potential Flu Pandemic
  • Kazakhstan
  • Kazakhstan Takes Proactive Measures Against Bird Flu
  • North Korea
  • North Korea Develops Bird Flu Vaccine
  • Vietnam
  • Vietnam to Mass-Produce Bird Flu Vaccines
  • Vietnam Imports Bird Flu Vaccine from Russia
  • Egypt
  • Egypt Reports H5N1 Infection in Vaccinated Flocks
  • Kenya
  • Kenya to Mass-Manufacture Vaccines Against Rift Valley Fever
  • Strategic Developments
  • Product Launches/Developments
  • Focus on Select players
  • Immunovaccine Technologies Inc. (Canada)
  • Imugene Limited (Australia)
  • Indian Immunologicals Ltd (India)
• B. Market Analytics
  • Table 67: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 68: Rest of World Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 69: Rest of World 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE